Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Pharmacogenet Genomics. 2010 Oct;20(10):575–585. doi: 10.1097/FPC.0b013e32833b04af

Table 2.

Kinetic analysis of 17-dihydroexemestane glucuronidation by individual HLM specimens from individuals stratified by UGT2B17 genotype

HLM No. UGT2B17 genotype Vmax (pmol/min/mg)a KM (μmol/l) Vmax/KM (μl/min/mg)a
972 (*1/*1) 51.6 10.6 4.9
1183 (*1/*1) 322 7.2 45.0
1392 (*1/*1) 393 7.1 55.0
2167 (*1/*1) 38.9 5.1 7.6
2412 (*1/*1) 213 6.7 32.0
mean ± SD 204 ± 158 7.3 ± 2.0 28.8 ± 22.3
383 (*2/*2) 17.0 9.3 1.8
416 (*2/*2) 5.6 17.0 0.3
2174 (*2/*2) 13.0 12.4 1.0
2175 (*2/*2) 2.3 13.0 0.2
3873 (*2/*2) 8.1 11.0 0.8
mean ± SD 9.2 ± 5.9 12.6 ± 3.0 0.8 ± 0.6
P valueb 0.025 0.012 0.023

HLM, human liver microsome.

a

Kinetic data expressed per mg HLM protein.

b

Comparing the UGT2B17 (*1/*1) versus (*2/*2) groups.